Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-16 Grissinger Michael Director Grant or award +3,135 6,024
2026-06-16 Grissinger Michael Director Grant or award · Stock Options (Right to Buy) +12,555 12,555
2025-06-05 Grissinger Michael Director Grant or award +1,045 2,889
2025-06-05 Grissinger Michael Director Grant or award · Stock Options (Right to Buy) +4,185 4,185
2024-06-20 Grissinger Michael Director Grant or award +1,045 1,844
2024-06-20 Grissinger Michael Director Grant or award · Stock Options (Right to Buy) +4,185 4,185
2023-08-23 Grissinger Michael Director Grant or award +500 799
2023-08-23 Grissinger Michael Director Grant or award · Stock Options (Right to Buy) +2,000 2,000
2022-07-28 Grissinger Michael Director Grant or award +5,995 5,995
2022-07-28 Grissinger Michael Director Grant or award · Stock Option (right to Buy) +29,575 29,575

Page 1 of 1 · 10 trades